Sino Medical Sciences Technology Inc. / Fundamentals
Income statement
- Net revenue
€58.36M - Cost of goods sold
€21.01M - Gross profit
€37.35M - SG&A expenses
€7.09M - R&D expenses
€15.87M - EBITDA
€1.91M - D&A
€0.00 - EBIT
€1.15M - Interest expenses
€638.77K - EBT
€1.27M - Tax expenses
€179.68K - Net income
€1.42M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€12.80M - Changes in working capital
€0.00 - Operating cash flow
€11.07M - Capex
€8.34M - Other investing cash flow
-€143.37K - Net investing cash flow
-€8.23M - Total cash dividends paid
-€505.12K - Issuance of common stock
€0.00 - Debt repayment
€411.08K - Other financing cash flow
€522.12K - Net financing cash flow
€428.07K - Foreign exchange effects
-€28.70K - Net change in cash
€12.68M - Cash at end of period
€40.68M - Free cash flow
€19.41M
Balance sheet
- Cash and cash equivalents
€40.68M - Cash and short-term investments
€40.68M - Total receivables
€3.20M - Inventory
€11.02M - Other current assets
€363.46K - Total current assets
€55.27M - Property, plant & equipment
€13.51M - Goodwill
€5.56M - Intangible assets
€70.02M - Long-term investments
€0.00 - Other non-current assets
€1.08M - Total non-current assets
€102.15M - Total assets
€157.43M - Accounts payable
€3.00M - Short-term debt
€10.39M - Other current liabilities
€8.94M - Total current liabilities
€23.08M - Long-term debt
€7.74M - Deferred tax liabilities
€4.63M - Other non-current liabilities
€9.88M - Total non-current liabilities
€23.19M - Total liabilities
€46.27M - Common stock
€50.01M - Retained earnings
-€26.37M - Other equity
€6.46M - Total equity
€111.16M - Total liabilities and shareholders' equity
€157.43M
Company information
- Market capitalization
€555.42M - Employees
652 - Enterprise Value
€4.48B
Company ratios
- Gross margin
-
64.0% Worse than peer group: 72.2% - EBITDA margin
-
3.3% Much worse than peer group: 32.1% - EBIT margin
-
2.0% Much worse than peer group: 32.2% - EBT margin
-
2.2% Much worse than peer group: 33.7% - Net margin
-
2.4% Much worse than peer group: 28.4% - ROE
-
1.3% Worse than peer group: 14.5% - ROA
-
0.9% Worse than peer group: 11.7% - Asset turnover
-
37.1% Worse than peer group: 42.5% - FCF margin
-
4.7% Worse than peer group: 12.9% - FCF yield
0.5% - Efficiency ratio
96.7% - Net sales per employee
-
€89.51K - Net income per employee
-
€2.18K